Provided by Tiger Fintech (Singapore) Pte. Ltd.

Viking Therapeutics

27.83
+0.79002.92%
Post-market: 27.850.0199+0.07%19:58 EDT
Volume:2.37M
Turnover:65.63M
Market Cap:3.13B
PE:-24.13
High:28.22
Open:27.24
Low:27.09
Close:27.04
Loading ...
Feb 07, 2024

Major Issues Report

Form 8-K - Current report
Feb 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 31, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 02, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 26, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 25, 2023

Major Issues Report

Form 8-K - Current report
Jul 27, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 26, 2023

Major Issues Report

Form 8-K - Current report
Jun 15, 2023

Major Issues Report

Form 8-K - Current report
May 16, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 16, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 11, 2023

Major Issues Report

8-K - Current report
May 01, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 26, 2023

Major Issues Report

8-K - Current report
Apr 26, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 24, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 19, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities